IP Library Granted Patent US 8,349,355
Granted Patent B2
US 8,349,355 · App. 11/921,247 · Granted Jan 8, 2013

Formulations of lipoic acid and hyaluroinc acid and/or the derivatives thereof in the pharmaceutical and cosmetic fields

Assignee: Anika Therapeutics S.R.L.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,349,355
App. No.
11/921,247
Granted
Jan 8, 2013
Kind
B2
Abstract

The present invention relates to novel formulations comprising lipoic acid and hyaluronic acid and/or the derivatives thereof for use in the repair of chronic ulcers, the regeneration of damaged skin, the prevention of skin aging and, when administered by the systemic route, to treat peripheral neuropathies and intoxications by chemical and/or biological agents.

Claims (12)

1. A topical composition comprising lipoic acid and the benzyl ester of hyaluronic acid with an esterification degree of 75%.

2. The composition according to claim 1 , wherein the percentage of lipoic acid varies between 0.5 and 15%.

3. The composition according to claim 2 , wherein the percentage of lipoic acid varies between 1 and 10%.

4. The composition according to claim 1 , in the form of non-woven fabric, cream, gel, lotion, or ointment.

5. The composition according to claim 4 in the form of a non-woven fabric.

6. A method of treating skin lesions which comprises topically applying thereto a combination of lipoic acid and of the benzyl ester of hyaluronic acid with an esterification degree of from 75%.

7. The method according to claim 6 , wherein the skin lesions are chronic ulcers, wounds, skin inflammation, autoimmune disorders, irritative, atopic or contact dermatitis, signs of aging or photoaging.

8. The method according to claim 7 which comprises topical treatment of chronic ulcers.

9. A process for preparing the composition according to claim 5 comprising the steps of:

preparing an ethanol solution of lipoic acid,

soaking in said solution a non-woven fabric made of the benzyl ester of hyaluronic acid with an esterification degree of 75%, and

drying the non-woven fabric by vacuum extraction on a hotplate.

Assignments (4)
CORRECTIVE ASSIGNMENT TOCORRECT THE CONVEYING PARTY'S NAME, PREVIOUSLY RECORDED ON REEL 026645, FRAME 0197. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Dec 19, 2011
From: FIDIA ADVANCED BIOP0LYMERS S.R.L.
To: ANIKA THERAPEUTICS S.R.L.
Reel/Frame 027468/0223 →
CORRECTIVE ASSIGNMENT TO CORREC THE CONVEYING PARTY'S NAME, PREVIOUSLY RECORDED ON REEL 026645, FRAME 0197. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Sep 6, 2011
From: FIDIA ADVANCED BIOPOLYMERS S.R.L.
To: ANIKA THERAPEUTICS S.R.L.
Reel/Frame 026906/0630 →
CHANGE OF NAME Recorded Jul 25, 2011
From: CARLO, SORANZO; DORIANA, SENIGAGLIA; DAVIDE, BELLINI
To: ANIKA THERAPEUTICS S.R.L.
Reel/Frame 026645/0197 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2009
From: SORANZO, CARLO; SENIGAGLIA, DORIANA; BELLINI, DAVIDE
To: FIDIA ADVANCED BIOPOLYMERS S.R.L.
Reel/Frame 022860/0106 →
Priority Claims (1)
IT PD2005A0168 · Jun 1, 2005 · national
Continuity (1)
Related Publication 20090304758A1 · Dec 10, 2009